No connection

Search Results

HQH

NEUTRAL
$19.61 Live
Abrdn Healthcare Investors · NYSE
$15.09 52W Range $20.46

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 28, 2026
Market cap
$1.12B
P/E
12.18
ROE
9.2%
Profit margin
1309.0%
Debt/Equity
N/A
Dividend yield
12.85%

AI Analysis

AI-powered fundamental assessment

Confidence
80%
HQH presents a complex profile with a stable Piotroski F-Score of 5/9 and a significant valuation discount, trading well below its Graham Number ($26.72) and Intrinsic Value ($47.5). However, these value metrics are offset by severe fundamental deterioration, specifically a -48.70% YoY revenue decline and an unsustainable dividend payout ratio of 139.13%. While historical price performance is positive, the current technical trend is heavily bearish (10/100) and liquidity is tight with a current ratio of 0.77. The stock is a value trap candidate where low multiples are justified by declining growth and dividend risk.

Key Strengths

Trading at a significant discount to Graham Number ($26.72) and Intrinsic Value ($47.5)
Low P/E ratio (12.18) compared to the Financial Services sector average (36.83)
Stable Piotroski F-Score of 5/9 indicating moderate financial health
Strong historical price appreciation over 1, 3, and 5-year horizons
Price-to-Book ratio of 1.00 suggests fair asset valuation

Key Risks

Unsustainable dividend payout ratio of 139.13%, signaling a high risk of dividend cuts
Severe revenue contraction of -48.70% YoY
Poor short-term liquidity with a current ratio of 0.77
Extremely bearish technical trend (10/100)
Lack of analyst coverage and institutional guidance
AI Fair Value Estimate
Based on comprehensive analysis
$24.5
+24.9% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
51
Moderate
Value
85
Future
20
Past
70
Health
50
Dividend
30
AI Verdict
Value Trap Warning
Key drivers: Deep valuation discount, Unsustainable dividend payout, Collapsing revenue growth, Bearish technicals
Confidence
85%
Value
85/100

Ref P/E 12.18, Graham Number $26.72

Positives
  • P/E well below sector average
  • Price < Graham Number
  • Price < Intrinsic Value
Watchpoints
  • Low multiples may reflect declining business quality
Future
20/100

Ref Revenue Growth (YoY)

Positives
  • Strong earnings growth (91.10%)
Watchpoints
  • Revenue growth -48.70%
  • Bearish technical trend
Past
70/100

Ref Historical Price Performance

Positives
  • Positive 1Y, 3Y, and 5Y returns
Watchpoints
  • Recent 1W decline
Health
50/100

Ref Piotroski F-Score, Current Ratio

Positives
  • Piotroski F-Score 5/9 (Stable)
Watchpoints
  • Current Ratio 0.77 (Liquidity risk)
  • No Altman Z-Score available
Dividend
30/100

Ref Yield 12.85%, Payout 139.13%

Positives
  • High nominal yield of 12.85%
Watchpoints
  • Payout ratio 139.13% is unsustainable

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$19.61

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for HQH and closest competitors.

Updated 2026-04-27
HQH
Abrdn Healthcare Investors
Primary
5Y
+34.1%
3Y
+61.5%
1Y
+38.9%
6M
+8.1%
1M
+12.5%
1W
-1.3%
FPF
First Trust Intermediate Duration Preferred & Income Fund
Peer
5Y
+14.1%
3Y
+58.3%
1Y
+16.0%
6M
+1.8%
1M
+3.7%
1W
-0.5%
HFW
Heritage Financial Corporation
Peer
5Y
+16.1%
3Y
+53.8%
1Y
+35.4%
6M
+22.3%
1M
+8.2%
1W
+4.6%
OCS
Oaktree Specialty Lending Corporation
Peer
5Y
+14.5%
3Y
-2.8%
1Y
+2.2%
6M
+3.6%
1M
+18.5%
1W
+7.5%
OSB
Old Second Bancorp, Inc.
Peer
5Y
+80.0%
3Y
+72.6%
1Y
+47.7%
6M
+19.1%
1M
+8.6%
1W
-1.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
12.18
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
1.0
P/S Ratio
148.88
EV/Revenue
144.5
EV/EBITDA
N/A
Market Cap
$1.12B

Profitability

Profit margins and return metrics

Profit Margin 1309.02%
Operating Margin -88.14%
Gross Margin 100.0%
ROE 9.16%
ROA -0.19%

Growth

Revenue and earnings growth rates

Revenue Growth -48.7%
Earnings Growth +91.1%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +103.5%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
0.77
Weak
Quick Ratio
0.74
Poor
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q3 2025

Total Assets
$1.1B
Liabilities
$0.0B
Equity
$1.1B
Debt/Equity
0.00x

Financial Services Sector Comparison

Comparing HQH against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
12.18
This Stock
vs
36.01
Sector Avg
-66.2% (Discount)
Return on Equity (ROE)
9.16%
This Stock
vs
-0.73%
Sector Avg
-1349.9% (Below Avg)
Profit Margin
1309.02%
This Stock
vs
91.62%
Sector Avg
+1328.8% (Superior)
Revenue Growth
-48.7%
This Stock
vs
35.27%
Sector Avg
-238.1% (Slower)
Current Ratio
0.77
This Stock
vs
3.18
Sector Avg
-75.9% (Weaker)

Similar Companies

Peer comparison within the same industry

Past News Coverage

Recent headlines mentioning HQH from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile